Journal article 485 views 92 downloads
Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial
John B. Buse,
Steve Bain
,
Johannes F.E. Mann,
Michael A. Nauck,
Steven E. Nissen,
Stuart Pocock,
Neil R. Poulter,
Richard E. Pratley,
Martin Linder,
Tea Monk Fries,
David D. Ørsted,
Bernard Zinman,
(on behalf of the LEADER Trial Investigators)
Diabetes Care, Start page: dc192251
Swansea University Author:
Steve Bain
-
PDF | Accepted Manuscript
Download (227.1KB)
DOI (Published version): 10.2337/dc19-2251
Abstract
Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial
Published in: | Diabetes Care |
---|---|
ISSN: | 0149-5992 1935-5548 |
Published: |
American Diabetes Association
2020
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa54312 |
first_indexed |
2020-05-26T19:08:06Z |
---|---|
last_indexed |
2023-01-11T14:32:17Z |
id |
cronfa54312 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2022-12-02T18:46:22.9114609</datestamp><bib-version>v2</bib-version><id>54312</id><entry>2020-05-26</entry><title>Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2020-05-26</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>Diabetes Care</journal><volume/><journalNumber/><paginationStart>dc192251</paginationStart><paginationEnd/><publisher>American Diabetes Association</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0149-5992</issnPrint><issnElectronic>1935-5548</issnElectronic><keywords/><publishedDay>4</publishedDay><publishedMonth>5</publishedMonth><publishedYear>2020</publishedYear><publishedDate>2020-05-04</publishedDate><doi>10.2337/dc19-2251</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><funders/><projectreference/><lastEdited>2022-12-02T18:46:22.9114609</lastEdited><Created>2020-05-26T14:43:37.4419580</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>John B.</firstname><surname>Buse</surname><order>1</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>2</order></author><author><firstname>Johannes F.E.</firstname><surname>Mann</surname><order>3</order></author><author><firstname>Michael A.</firstname><surname>Nauck</surname><order>4</order></author><author><firstname>Steven E.</firstname><surname>Nissen</surname><order>5</order></author><author><firstname>Stuart</firstname><surname>Pocock</surname><order>6</order></author><author><firstname>Neil R.</firstname><surname>Poulter</surname><order>7</order></author><author><firstname>Richard E.</firstname><surname>Pratley</surname><order>8</order></author><author><firstname>Martin</firstname><surname>Linder</surname><order>9</order></author><author><firstname>Tea Monk</firstname><surname>Fries</surname><order>10</order></author><author><firstname>David D.</firstname><surname>Ørsted</surname><order>11</order></author><author><firstname>Bernard</firstname><surname>Zinman</surname><order>12</order></author><author><firstname>(on behalf of the LEADER Trial</firstname><surname>Investigators)</surname><order>13</order></author></authors><documents><document><filename>54312__17348__52ec1b57101b4525b4bb633908ab57fd.pdf</filename><originalFilename>Buse2020.pdf</originalFilename><uploaded>2020-05-26T14:44:34.8817465</uploaded><type>Output</type><contentLength>232546</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807> |
spelling |
2022-12-02T18:46:22.9114609 v2 54312 2020-05-26 Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2020-05-26 MEDS Journal Article Diabetes Care dc192251 American Diabetes Association 0149-5992 1935-5548 4 5 2020 2020-05-04 10.2337/dc19-2251 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2022-12-02T18:46:22.9114609 2020-05-26T14:43:37.4419580 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine John B. Buse 1 Steve Bain 0000-0001-8519-4964 2 Johannes F.E. Mann 3 Michael A. Nauck 4 Steven E. Nissen 5 Stuart Pocock 6 Neil R. Poulter 7 Richard E. Pratley 8 Martin Linder 9 Tea Monk Fries 10 David D. Ørsted 11 Bernard Zinman 12 (on behalf of the LEADER Trial Investigators) 13 54312__17348__52ec1b57101b4525b4bb633908ab57fd.pdf Buse2020.pdf 2020-05-26T14:44:34.8817465 Output 232546 application/pdf Accepted Manuscript true true eng |
title |
Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial |
spellingShingle |
Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial Steve Bain |
title_short |
Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial |
title_full |
Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial |
title_fullStr |
Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial |
title_full_unstemmed |
Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial |
title_sort |
Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial |
author_id_str_mv |
5399f4c6e6a70f3608a084ddb938511a |
author_id_fullname_str_mv |
5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain |
author |
Steve Bain |
author2 |
John B. Buse Steve Bain Johannes F.E. Mann Michael A. Nauck Steven E. Nissen Stuart Pocock Neil R. Poulter Richard E. Pratley Martin Linder Tea Monk Fries David D. Ørsted Bernard Zinman (on behalf of the LEADER Trial Investigators) |
format |
Journal article |
container_title |
Diabetes Care |
container_start_page |
dc192251 |
publishDate |
2020 |
institution |
Swansea University |
issn |
0149-5992 1935-5548 |
doi_str_mv |
10.2337/dc19-2251 |
publisher |
American Diabetes Association |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
document_store_str |
1 |
active_str |
0 |
published_date |
2020-05-04T07:39:13Z |
_version_ |
1828634286747549696 |
score |
11.056659 |